Abstract
Several proponents believe a universal healthcare system might have allowed the United States to navigate the COVID-19 pandemic more effectively, potentially leading to less devastating outcomes. Yet, comprehensive studies assessing this assertion on an international scale across multiple pandemic phases are sparse. This study evaluates the COVID-19 response efficacy in OECD countries, contrasting single-payer with multiple-payer healthcare frameworks. Data from different pandemic phases through to October 2023, suggest a single-payer system correlate with reduced death rates, diminished excess mortality, and overall lower cumulative excess mortality. Notably, among the high-income OECD nations, the U.S. ranks lowest in pandemic response. Such findings underscore the significant impact of disparities in healthcare access. Essentially, these inequities can debilitate a healthcare infrastructure to the extent that it lags nations with similar socio-economic, demographic, and health profiles.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.